Form 4: Abeona Therapeutics Director Michael Amoroso Acquires Shares as Part of Annual Board Grant

Director Michael Amoroso reports acquisition of Abeona Therapeutics shares as part of the company's annual board grant.

Summary

• On August 26, 2024, Michael Amoroso, a director of Abeona Therapeutics Inc., acquired 11,797 shares of common stock.
• The acquisition was part of the 2024 annual stock grant to the board of directors.
• This portion of the grant was withheld until employee/management share allocation and onboarding of new board members.
• The shares were acquired at a price of $0.
• Following the transaction, Amoroso directly owns 144,365 shares of Abeona Therapeutics Inc.
• All of the restricted stock will vest on August 26, 2025.

Sentiment

Score: 7

Explanation: The sentiment is neutral to positive as it reflects standard executive compensation practices and alignment of interests. There are no indications of negative events or concerns.

Positives

• Director Amoroso's acquisition of shares demonstrates continued alignment with the company's success.
• The stock grant serves as an incentive for board members.

Future Outlook

The document does not contain specific forward-looking statements beyond the vesting date of the restricted stock.

Industry Context

This filing is a routine disclosure related to executive compensation and stock ownership, common in publicly traded companies.

Stakeholder Impact

• The stock grant aligns the director's interests with those of shareholders.
• The vesting schedule encourages long-term commitment.

Key Dates